Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HIF1A | Q16665 | 18/20 | 0.55 |
| ▸ | CDK2 | P24941 | 1/20 | 0.46 |
| ▸ | ALB | P02768 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6833104 | 0.89 | HIF1A (0.49) | HIF1ACDK2ALB | |
| SCHEMBL6834186 | 0.89 | HIF1A (0.49) | HIF1ACDK2ALB | |
| SCHEMBL6821929 | 0.88 | ALB (0.43) | HIF1ACDK2ALB | |
| SCHEMBL6814370 | 0.86 | ALB (0.42) | HIF1ACDK2ALB | |
| SCHEMBL6830124 | 0.86 | AKR1C2 (0.43) | HIF1ACDK2ALB | |
| SCHEMBL6813915 | 0.86 | ALB (0.42) | HIF1ACDK2ALB | |
| SCHEMBL6830664 | 0.86 | HIF1A (0.44) | HIF1AALB | |
| SCHEMBL6830641 | 0.86 | AKR1C2 (0.43) | HIF1AALB | |
| SCHEMBL6834155 | 0.86 | F2 (0.50) | HIF1AALB | |
| SCHEMBL6818222 | 0.85 | ALB (0.48) | HIF1AALB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040110802-A1 | Antibacterial benzoic acid derivatives | PHARMACIA & UPJOHN COMPANY | 2004-06-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040110802-A1 | Antibacterial benzoic acid derivatives | GABRD, GABBR1, GABRA1 | HIF1A 220/4885CDK2 4509/4885ALB 1417/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.